Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood

Recruiting

I'm Interested

Trial ID: NCT03638427

Age - 18 Years-N/A Gender - Female Accepting Healthy Volunteers - yes

Purpose

The purpose of this study is to investigate the feasibility and efficacy of assessing HR-HPV DNA and HPV E6/E7 mRNA via self-collected menstrual blood in a smart menstrual pad. In other words, can the investigators detect the high risk strains of the human papilloma virus (HPV) that are associated with cervical cancer in self-collected menstrual blood, as an alternative to collecting vaginal swabs.

Official Title

Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood

Stanford Investigator(s)

Paul D. Blumenthal, MD, MPH
Paul D. Blumenthal, MD, MPH

Professor of Obstetrics and Gynecology (Gynecology-Family Planning) at the Stanford University Medical Center, Emeritus

Eligibility


Inclusion Criteria:

There will be two study groups: 1) menstruating women over the age of 18 who have previous
history of HR-HPV in the last 18 months and 2) menstruating women over the age of 18 who do
not have a previous history of HR-HPV.

Exclusion Criteria:

   - Women younger than 18 years old or are not menstruating regularly

View More
View Less

Intervention(s):

diagnostic test: Menstrual Blood Analysis (Menstrual Blood Analysis)

Recruiting

I'm Interested

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Klaira M Lerma, MPH
16507211562

©2024 Stanford Medicine